MALIGNANT PLEURAL EFFUSIONS (MPE)- PLEURODESIS

Clinical trials for MALIGNANT PLEURAL EFFUSIONS (MPE)- PLEURODESIS explained in plain language.

Never miss a new study

Get alerted when new MALIGNANT PLEURAL EFFUSIONS (MPE)- PLEURODESIS trials appear

Sign up with your email to follow new studies for MALIGNANT PLEURAL EFFUSIONS (MPE)- PLEURODESIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New combo therapy targets tough lung cancer complication

Disease control Not yet recruiting

This study tests whether combining the drug furmonertinib with chest radiation can help control EGFR-positive lung adenocarcinoma that has spread to the lining of the lung, causing fluid buildup. About 63 adults will receive the treatment to see if it delays cancer growth. Resear…

Matched conditions: MALIGNANT PLEURAL EFFUSIONS (MPE)- PLEURODESIS

Phase: PHASE2 • Sponsor: Jiangmen Central Hospital • Aim: Disease control

Last updated May 06, 2026 16:03 UTC

MALIGNANT PLEURAL EFFUSIONS (MPE)- PLEURODESIS

Get alerted when new MALIGNANT PLEURAL EFFUSIONS (MPE)- PLEURODESIS trials appear

New combo therapy targets tough lung cancer complication